from    
to    
search  

 


脑机接口时代,我们还能做什么?——脑科学驱动下的神经外科蜕变与新生
Novel Materials Chemistry for Energy and Environmental Applications
清华大学材料科学与工程研究院《材料科学论坛》:超快激光诱导玻璃微纳结构—现象、机...
创新药可及的全球视野和中国现状
报告题目:
Development and Production of Human Biotherapeutics
 报告人:
James Leung
Visiting Scientist 

Biology department & Center for Biomedical Innovations,MIT
报告时间:
2010-03-02 10:30
报告地点:
化学工程系(工物馆 324-东 会议室)
主办单位:
化学工程系
  简介:

Dr. Leung is a Visiting Scientist at MIT participating in biotechnology research projects in the Biology and Chemical Engineering departments. He also engages with biotechnology and pharmaceutical companies by serving as consulting advisor in the areas of biotherapeutic development and manufacturing.

 

For the last ten years, Dr. Leung was the Vice President of Biotechnology at Ipsen, an international pharmaceutical company headquartered in France and the United Kingdom. Prior to Ipsen, from 1995 to 1998, he worked as an independent consultant advising startup biotechnology companies in the United States and Asia, and served as industrial coordinator for two consortia at MIT – BioProcess Engineering Center (BPEC) and Consortium for the Advanced Manufacturing of Pharmaceuticals (CAMP). From 1993 to 1995, Dr. Leung was the Senior Vice President of Operations at Repligen Corp., a public biotechnology company focused on developing novel therapeutics for neurological disorders. Dr. Leung started his biotechnology career at Genentech, Inc.

 

Dr. Leung received a B.Sc. degree from the Chemical Engineering Department at MIT, and a M.Sc. degree and a Ph.D. degree in biochemical engineering from MIT.

今日相关信息
中国发展道路研讨会暨《中国向何处去》和《...
 
同类别相关信息
构建多相系统,创新生物保存
Publishing with the Royal Society o...
【清华五道口全球名师大讲堂】欧元二十年...
Journal publishing workshop
活动因故取消,请大家相互转告!MSTA ...
学术活动